LON/0R2S (LON/0R2S)

London Stock Exchange: LON/0R2S · USD

$304

+1.57 (+0.5%)· Recorded snapshot

Market cap	86.9B
Revenue (ttm)	19.5B
Net income (ttm)	2.8B
EPS (ttm)	$7.25
P/E (trailing)	31.5x
P/E (forward)	18.9x
Dividend	$2.65 (1.16%)
Volume	2,208
Beta	0.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 19.5B
Net income (ttm): 2.8B
EPS (ttm): $7.25
P/E (trailing): 31.5x
P/E (forward): 18.9x
Market cap: 86.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.9

P25 n/aP50 n/aP75 n/a

Trailing P/E31.5

P25 n/aP50 n/aP75 n/a

ROE16.5

P25 n/aP50 n/aP75 n/a

ROIC12.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LON/0R2S indicators

Market & fundamental data

Available fields

253

Groups with data

Currency

USD

Showing 253 of 253 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	United States
Country code	UK
Earnings date	2026-10-29
Employees	56,000
Employees change	3,000
Employees growth	5.66%
Enterprise value	$95.9B
Exchange	London Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1941
Industry	Medical Devices
Is primary listing	No
ISIN number	US8636671013
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	$86.9B
Next earnings date	2026-10-29
Price	$303.59
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	lon/0R2S
Website	https://www.stryker.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	40.49x
Average P/E ratio (3Y)	41.62x
Average P/E ratio (5Y)	42.15x
Earnings yield	3.18%
EV/Earnings	34.11x
EV/EBIT	20.73x
EV/EBITDA	16.82x
EV/FCF	27.05x
EV/Sales	4.94x
FCF / EV yield	3.7%
FCF yield	4.08%
Forward P/E	18.87x
Graham number	118.1482
Graham upside	-61.08%
Industry forward P/E	13.63x
Industry P/E	21.46x
Lynch fair value	$121.30
Lynch upside	-60.04%
P/(FCF - SBC) ratio	25.9x
P/(OCF - SBC) ratio	21.86x
P/B ratio	4.81x
P/E ratio	31.46x
P/FCF ratio	24.52x
P/OCF ratio	20.86x
P/S ratio	4.46x
Price/EBITDA ratio	15.63x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	23.82%
EBITDA margin	28.55%
Effective tax rate	27.56%
FCF margin	18.26%
Gross margin	65.59%
Operating margin	23.82%
Pretax margin	19.92%
Profit margin	14.43%
Profit per employee	$50,188
Profitable quarters	24
Profitable years	14
Revenue per employee	$347,738
ROA	8.16%
ROA (5Y)	6.99%
ROCE	14.92%
ROE	16.51%
ROE (5Y)	15.51%
ROIC	12.52%
ROIC (5Y)	12.85%
SBC / revenue	0.97%
Tax / revenue	5.49%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	27.79%
EPS growth (Q)	44.11%
EPS growth (QoQ)	70.98%
EPS growth 10Y	8.57%
EPS growth 3Y	10.87%
EPS growth 5Y	12.08%
EPS growth quarters	5
EPS growth years	1
FCF growth	16.85%
FCF growth (Q)	14.12%
FCF growth (QoQ)	155.18%
FCF growth 3Y	24.83%
FCF growth 5Y	9.6%
Gross profit growth	9.54%
Gross profit growth (Q)	15.26%
Gross profit growth 3Y	11.36%
Gross profit growth 5Y	9.73%
Net income growth	27.79%
Net income growth (Q)	44.34%
Net income growth (QoQ)	71.28%
Net income growth 3Y	11.24%
Net income growth 5Y	12.35%
Net income growth quarters	5
Net income growth years	1
OCF growth	15.93%
OCF growth (Q)	13.5%
OCF growth (QoQ)	117.04%
OCF growth 10Y	19.67%
OCF growth 3Y	22.24%
OCF growth 5Y	10.22%
Operating income growth	16.4%
Operating income growth (Q)	34.64%
Operating income growth 3Y	17.73%
Operating income growth 5Y	10.8%
Revenue growth	8.48%
Revenue growth (Q)	9.42%
Revenue growth (QoQ)	9.45%
Revenue growth 10Y	9.45%
Revenue growth 3Y	9.92%
Revenue growth 5Y	9.72%
Revenue growth quarters	24
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-620.3M
Depreciation and amortization	$916.9M
EBIT	$4.6B
EBITDA	$5.6B
EPS	$7.25
Financing cash flow	$-2.3B
Free cash flow	$3.5B
Free cash flow minus SBC	$3.4B
Gross profit	$12.8B
Income taxes	$1.1B
Investing cash flow	$-1.1B
Net borrowing	$-1.1B
Net cash flow	$765.8M
Net income	$2.8B
Operating cash flow minus SBC	$4B
Operating income	$4.6B
Revenue	$19.5B
Stock-based compensation	$189.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.21
Book value per share	$47.14
Debt / EBITDA	2.04
Debt / equity	0.64
Debt / FCF	3.28
Goodwill	$14.7B
Interest coverage	10.26
Long-term assets	$25.3B
Long-term liabilities	$13B
Net cash (debt)	$-9B
Net cash / market cap	-10.38%
Net debt / EBITDA	1.62
Net debt / equity	0.5
Net debt / FCF	2.55
Piotroski F-Score	7
Property, plant and equipment	$3.4B
Shareholders' equity	$18.1B
Tangible book value	$-1B
Tangible book value per share	$-2.63
Total assets	$36.1B
Total cash	$2.6B
Total debt	$11.6B
Total liabilities	$18B
WACC	7.87%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.55
Current assets	$10.8B
Current liabilities	$5B
Current ratio	2.16
Inventory turnover	1.64
Net working capital	$3.9B
Quick ratio	1.08
Working capital	$5.8B
Working capital turnover	2.9

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.05%
Dividend growth	4.76%
Dividend growth (3Y)	5.47%
Dividend growth (5Y)	6.91%
Dividend growth years	9
Dividend payment date	2026-10-30
Dividend payment years	11
Dividend payout frequency	Quarterly
Dividend per share	$2.65
Dividend yield	1.16%
Ex-dividend date	2026-09-30
Last dividend	$0.88
Payout ratio	35.32%
Shareholder yield	1.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$312.18
1D price change	0.52%
1M price change	10.82%
1M total return	11.17%
1W price change	-0.39%
1W total return	-0.39%
1Y price change	-20.44%
1Y return CAGR	-19.57%
1Y total return	-19.56%
20-day SMA	$290.00
200-day SMA	$324.42
3M price change	-9.86%
3M total return	-9.58%
3Y price change	16.73%
3Y return CAGR	6.33%
3Y total return	20.23%
50-day SMA	$293.76
50-day SMA vs 200-day SMA	50under200
52-week high	$389.55
52-week high date	2026-03-03
52-week low	$267.14
52-week low date	2026-09-11
5Y price change	12.85%
5Y return CAGR	3.53%
5Y total return	18.96%
6M price change	-7.35%
6M total return	-6.81%
All-time high	$406.70
All-time high date	2025-01-28
All-time low	$84.19
All-time low date	2014-11-06
Average true range (ATR)	$11.91
Average volume	2.2K
Beta (5Y)	0.78
Change from 52-week high	-22.07%
Change from 52-week low	13.64%
Change from all-time high	-25.35%
Change from all-time low	260.6%
Change from open	1.8%
Day's gap	-1.25%
Dollar volume	$670,327
High price	$307.68
Low price	$294.41
Monthly RSI	43.01
Open price	$298.22
Position in 52-week range	69.18%
Previous close	$302.01
Price vs 150-day SMA	-2.75%
Price vs 20-day SMA	4.69%
Price vs 200-day SMA	-6.42%
Price vs 50-day SMA	3.35%
Relative volume	1.05
RSI	58.47
Sharpe ratio	-0.73
Sharpe ratio (3Y)	0.15
Sharpe ratio (5Y)	0.13
Sortino ratio	-0.79
Sortino ratio (3Y)	0.44
Sortino ratio (5Y)	0.41
Volume	2.2K
Weekly RSI	46.39
YTD price change	-14.18%
YTD total return	-13.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	348.1M
Shares change (QoQ)	-0.13%
Shares change (YoY)	0.05%
Shares held by insiders	9.14%
Shares held by institutions	81.99%
Short ratio	2.2 days

Deeper analysis on LON/0R2S

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LON/0R2S report

Is a complete LON/0R2S research report available?

No complete published report is available for lon/0R2S (LON/0R2S) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LON/0R2S (LON/0R2S)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0R2S

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0R2S indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LON/0R2S

Frequently asked questions